Thermo Fisher Scientific (FRA:TN8) LT-Debt-to-Total-Asset : 0.32 (As of Mar. 2024)

View and export this data going back to 1980. Start your Free Trial

What is Thermo Fisher Scientific LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Thermo Fisher Scientific's long-term debt to total assests ratio for the quarter that ended in Mar. 2024 was 0.32.

Thermo Fisher Scientific's long-term debt to total assets ratio increased from Mar. 2023 (0.31) to Mar. 2024 (0.32). It may suggest that Thermo Fisher Scientific is progressively becoming more dependent on debt to grow their business.

Thermo Fisher Scientific LT-Debt-to-Total-Asset Historical Data

The historical data trend for Thermo Fisher Scientific's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thermo Fisher Scientific LT-Debt-to-Total-Asset Chart

Thermo Fisher Scientific Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.29

0.28

0.34

0.30

0.32

Thermo Fisher Scientific Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.31	0.31	0.31	0.32	0.32

Thermo Fisher Scientific LT-Debt-to-Total-Asset Calculation

Thermo Fisher Scientific's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	28709.436	/	90531.742
	=	0.32

Thermo Fisher Scientific's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (Q: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )	/	Total Assets (Q: Mar. 2024 )
	=	28664.44	/	89327.4
	=	0.32

Thermo Fisher Scientific (FRA:TN8) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Thermo Fisher Scientific LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Thermo Fisher Scientific's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Thermo Fisher Scientific (FRA:TN8) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Thermo Fisher Scientific Inc (FRA:TN8) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

TMO:USA TMO:Peru TMO:Mexico TN8:Germany TN8:Germany TMOS34:Brazil TMO:Argentina

Address

168 Third Avenue, Waltham, MA, USA, 02451

Website

https://www.thermofisher.com

Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2023 (revenue figures include some cross-segment revenue): analytical technologies (16% of sales); specialty diagnostic products (10%); life science solutions (24%); and lab products and services, which includes CRO services (54%).

Thermo Fisher Scientific (FRA:TN8) Headlines

No Headlines